The United Kingdom expanded its Global Talent visa scheme on 6 August 2026, enabling more than 100 UK research-intensive companies to endorse exceptional researchers for visas to live and work in the country. Previously, only universities and research institutes could endorse Global Talent visa applicants through the funder pathway; now approved businesses such as AstraZeneca and Jaguar Land Rover also endorse applicants.
Expansion Includes AstraZeneca, Jaguar Land Rover, and Innovators
The expansion includes added businesses like Added Value Solutions (AVS), Denroy Plastics, and Ffilm Cymru, covering sectors such as clean energy, life sciences, AI, advanced manufacturing, digital technologies, and the creative industries. These companies are part of the
eight high-growth sectors identified in the UK government’s Modern Industrial Strategy.
Broadened Access to Fast-Track Visa Routes
The Global Talent visa recognizes individuals at all career stages via four endorsement pathways: academic appointments (fast-track), individual fellowships (fast-track), endorsed funders (fast-track), and peer review. In April 2026, the Academic Appointments route was simplified to cover all roles at approved UK academic, research, or innovation leadership institutions and all PhD-level roles primarily focused on research and innovation.
Driving Innovation and Economic Growth Across the UK
More than 12,500 talented individuals from over 130 countries have been helped to build research careers in the UK through the endorsed funder route before this expansion. The government has invested
£54 million in the Global Talent Fund, which has attracted 18 leading research group leaders so far.
UK Research and Innovation (UKRI) plans to broaden the Future Technology Research and Innovation (FTRI) scheme under the Government Authorised Exchange visa. This scheme enables more R&D-focused companies to host international researchers, scientists, interns and specialists for placements lasting up to two years.
Industry and Expert Endorsements Highlight Scheme Benefits
Jonathan Reynolds, Secretary of State for Business, Innovation, Science and Trade, stated the visa expansion helps innovative UK companies recruit eligible researchers who will develop future medicines, technologies, and industries in the UK. Professor Christopher Smith, UKRI International, Talent and
Skills Champion, highlighted that expansion spreads benefits across many sectors nationwide, from medicines and AI to the creative and cultural economy.
Oliver Buckley-Mellor of the Association of the British Pharmaceutical Industry (ABPI) said opening the endorsed funder route to businesses addresses a key gap in the UK’s global talent offer. Jonathan Legh-Smith from UKQuantum emphasized the importance of attracting world-class quantum expertise, while Kate Barclay MBE of the BioIndustry Association noted the expansion helps life sciences and biotech companies access specialist skills. Steve Brierley, CEO and founder of Riverlane, cited the visa as a fast and flexible route to bring
global quantum computing talent to the UK.
